Touchlight awarded Innovate UK grant for the measurement and intracellular visualisation of synthetic DNA constructs
Lonza and Touchlight collaborate on end-to-end mRNA offering
Touchlight awarded ILAP for therapeutic DNA vaccine
Touchlight signs patent license agreement with Pfizer for the use of dbDNA for the manufacture of mRNA-based vaccines, therapeutics and gene therapies
Touchlight and Versameb announce GMP manufacturing supply agreement
AskBio and Touchlight Restructure Joint Venture
Touchlight Ranked Number Four Fastest Growing Technology Company in the UK in the 2021 Deloitte Technology Fast 50
Touchlight to break ground on world’s highest-capacity DNA manufacturing facility
Touchlight expands commercial team amid rapid company growth
Touchlight extends funding round to US$125M as demand for its dbDNA™ grows rapidly
Touchlight and Vanderbilt University Medical Center collaborate on DARPA Pandemic Prevention Platform programme to develop synthetic DNA-based antibody to protect against emerging threats
Touchlight raises £42 million ($58 million) to meet unprecedented global DNA demand
Biotech Week Boston
Join us at Cell & Gene Therapy, part of Biotech Week Boston (Sep 27-30, 2022).
We’ll be available on Booth 133 to discuss your requirements for advanced therapy manufacturing.
Visit us and learn how our doggybone DNA can be used to enable faster, safer and more scalable DNA production than other traditional methods without contamination of the plasmid DNA backbone.